Terms: = Leukemia AND SERPINE1, PAI, PAI-1, PAI1, PLANH1
125 results:
1. Pharmacotherapeutic advances for chronic myelogenous leukemia: beyond tyrosine kinase inhibitors.
Costa A; Scalzulli E; Carmosino I; Ielo C; Bisegna ML; Martelli M; Breccia M
Expert Opin Pharmacother; 2024 Feb; 25(2):189-202. PubMed ID: 38488824
[TBL] [Abstract] [Full Text] [Related]
2. miR-181a plays the tumor-suppressor role in chronic myeloid leukemia CD34
Zhang X; Ma W; Xue W; Wang Y; Chen P; Li Q; Li YY; Hu X; Zhao Y; Zhou H
Cell Mol Life Sci; 2023 Dec; 81(1):10. PubMed ID: 38103082
[TBL] [Abstract] [Full Text] [Related]
3. Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosis.
Moreno-Castaño AB; Fernández S; Ventosa H; Palomo M; Martinez-Sanchez J; Ramos A; Ortiz-Maldonado V; Delgado J; Fernández de Larrea C; Urbano-Ispizua A; Penack O; Nicolás JM; Téllez A; Escolar G; Carreras E; Fernández-Avilés F; Castro P; Diaz-Ricart M
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37045474
[TBL] [Abstract] [Full Text] [Related]
4. Deep molecular response in patients with chronic phase chronic myeloid leukemia treated with the plasminogen activator inhibitor-1 inhibitor TM5614 combined with a tyrosine kinase inhibitor.
Takahashi N; Kameoka Y; Onizuka M; Onishi Y; Takahashi F; Dan T; Miyata T; Ando K; Harigae H
Cancer Med; 2023 Feb; 12(4):4250-4258. PubMed ID: 36151699
[TBL] [Abstract] [Full Text] [Related]
5. TM5614, an Inhibitor of Plasminogen Activator Inhibitor-1, Exerts an Antitumor Effect on Chronic Myeloid leukemia.
Sasaki K; Fujiwara T; Ochi T; Ono K; Kato H; Onodera K; Ichikawa S; Fukuhara N; Onishi Y; Yokoyama H; Miyata T; Harigae H
Tohoku J Exp Med; 2022 Jun; 257(3):211-224. PubMed ID: 35491124
[TBL] [Abstract] [Full Text] [Related]
6. [Bioinformatics screening and analysis of key differentially expressed genes characteristics in nonalcoholic fatty liver disease].
Ding JX; Huang WB; Jiang XX; Zhang LD; Fang H; Jin J
Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):297-303. PubMed ID: 35462486
[No Abstract] [Full Text] [Related]
7. Biomarkers of Glucose Metabolism Alterations and the Onset of Metabolic Syndrome in Survivors of Childhood Acute Lymphoblastic leukemia.
Konończuk K; Muszyńska-Rosłan K; Konstantynowicz-Nowicka K; Krawczuk-Rybak M; Chabowski A; Latoch E
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409072
[TBL] [Abstract] [Full Text] [Related]
8. Novel chemotherapeutic agent FX-9 activates NF-κB signaling and induces G1 phase arrest by activating CDKN1A in a human prostate cancer cell line.
Weiner F; Schille JT; Koczan D; Wu XF; Beller M; Junghanss C; Hewicker-Trautwein M; Murua Escobar H; Nolte I
BMC Cancer; 2021 Oct; 21(1):1088. PubMed ID: 34625047
[TBL] [Abstract] [Full Text] [Related]
9. Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes.
Fernández S; Moreno-Castaño AB; Palomo M; Martinez-Sanchez J; Torramadé-Moix S; Téllez A; Ventosa H; Seguí F; Escolar G; Carreras E; Nicolás JM; Richardson E; García-Bernal D; Carlo-Stella C; Moraleda JM; Richardson PG; Díaz-Ricart M; Castro P
Shock; 2022 Jan; 57(1):95-105. PubMed ID: 34172614
[TBL] [Abstract] [Full Text] [Related]
10. Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor-1 and osteonecrosis risk in childhood acute lymphoblastic leukemia.
Sherief LM; Beshir M; Raafat N; Abdelkhalek ER; Mokhtar WA; Elgerby KM; Soliman BK; Salah HE; Mokhtar GA; Kamal NM; ELsayed H; Zakaria M
Mol Genet Genomic Med; 2021 Jul; 9(7):e1700. PubMed ID: 34042331
[TBL] [Abstract] [Full Text] [Related]
11. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL).
Zarei-Ghobadi M; Sheikhi M; Teymoori-Rad M; Yaslianifard S; Norouzi M; Yaslianifard S; Faraji R; Farahmand M; Bayat S; Jafari M; Mozhgani SH
BMC Res Notes; 2021 Mar; 14(1):109. PubMed ID: 33757561
[TBL] [Abstract] [Full Text] [Related]
12. Studies on the changes of uPA system in a co-culture model of bone marrow stromal cells-leukemia cells.
Zhou L; Guo H; Jia F; Chen X; Zhang X; Dong S; Zhao L
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146708
[TBL] [Abstract] [Full Text] [Related]
13. Targeting of plasminogen activator inhibitor-1 activity promotes elimination of chronic myeloid leukemia stem cells.
Yahata T; Ibrahim AA; Hirano KI; Muguruma Y; Naka K; Hozumi K; Vaughan DE; Miyata T; Ando K
Haematologica; 2021 Feb; 106(2):483-494. PubMed ID: 32001531
[TBL] [Abstract] [Full Text] [Related]
14. TP53/miR-34a-associated signaling targets
Akula SM; Ruvolo PP; McCubrey JA
Aging (Albany NY); 2020 Jan; 12(3):2777-2797. PubMed ID: 31986125
[TBL] [Abstract] [Full Text] [Related]
15. Bisphenol compounds regulate decidualized stromal cells in modulating trophoblastic spheroid outgrowth and invasion in vitro†.
Fan H; Jiang L; Lee YL; Wong CKC; Ng EHY; Yeung WSB; Lee KF
Biol Reprod; 2020 Mar; 102(3):693-704. PubMed ID: 31742322
[TBL] [Abstract] [Full Text] [Related]
16. The regulation of inflammation-related genes after palmitic acid and DHA treatments is not mediated by DNA methylation.
Samblas M; Carraro JC; Martínez JA; Milagro FI
J Physiol Biochem; 2019 Aug; 75(3):341-349. PubMed ID: 31423543
[TBL] [Abstract] [Full Text] [Related]
17. pai-1 and protein C as early markers of veno-occlusive disease in patients treated for Wilms tumor.
Cesaro S; Mauro M; Sattin G; Sartori MT; Saggiorato G; Paratella A; Tridello G; Bisogno G
Pediatr Blood Cancer; 2019 Jul; 66(7):e27695. PubMed ID: 30865371
[TBL] [Abstract] [Full Text] [Related]
18. Quantitative measurement of selected protein biomarkers of endothelial dysfunction in plasma by micro-liquid chromatography-tandem mass spectrometry based on stable isotope dilution method.
Suraj J; Kurpińska A; Sternak M; Smolik M; Niedzielska-Andres E; Zakrzewska A; Sacha T; Kania A; Chlopicki S; Walczak M
Talanta; 2019 Mar; 194():1005-1016. PubMed ID: 30609507
[TBL] [Abstract] [Full Text] [Related]
19. Endothelial Function in Children with Acute Lymphoblastic leukemia (ALL) May Reflect the Clinical Outcome.
Doroszko A; Niedzielska E; Jakubowski M; Porwolik J; Turek-Jakubowska A; Szahidewicz-Krupska E; Sieczkowski B; Dobrowolski P; Radziwon A; Skomro R; Derkacz A; Mazur G; Chybicka A; Szuba A
Biomed Res Int; 2018; 2018():7918091. PubMed ID: 30534565
[TBL] [Abstract] [Full Text] [Related]
20. Circadian locomotor output cycles kaput accelerates atherosclerotic plaque formation by upregulating plasminogen activator inhibitor-1 expression.
Jiang Q; Liu H; Wang S; Wang J; Tang Y; He Z; Wu F; Huang Z; Cong X; Ding R; Liang C
Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):869-879. PubMed ID: 30124738
[TBL] [Abstract] [Full Text] [Related]
[Next]
